RNA binding specificity of Ebola virus transcription factor VP30.
The transcription factor VP30 of the non-segmented RNA negative strand Ebola virus balances viral transcription and replication. Here, we comprehensively studied RNA binding by VP30. Using a novel VP30:RNA electrophoretic mobility shift assay, we tested truncated variants of 2 potential natural RNA substrates of VP30 - the genomic Ebola viral 3'-leader region and its complementary antigenomic counterpart (each ∼155 nt in length) - and a series of other non-viral RNAs. Based on oligonucleotide interference, the major VP30 binding region on the genomic 3'-leader substrate was assigned to the internal expanded single-stranded region (∼ nt 125-80). Best binding to VP30 was obtained with ssRNAs of optimally ∼ 40 nt and mixed base composition; underrepresentation of purines or pyrimidines was tolerated, but homopolymeric sequences impaired binding. A stem-loop structure, particularly at the 3'-end or positioned internally, supports stable binding to VP30. In contrast, dsRNA or RNAs exposing large internal loops flanked by entirely helical arms on both sides are not bound. Introduction of a 5´-Cap(0) structure impaired VP30 binding. Also, ssDNAs bind substantially weaker than isosequential ssRNAs and heparin competes with RNA for binding to VP30, indicating that ribose 2'-hydroxyls and electrostatic contacts of the phosphate groups contribute to the formation of VP30:RNA complexes. Our results indicate a rather relaxed RNA binding specificity of filoviral VP30, which largely differs from that of the functionally related transcription factor of the Paramyxoviridae which binds to ssRNAs as short as 13 nt with a preference for oligo(A) sequences.
a Institut für Pharmazeutische Chemie, Philipps-Universität Marburg , Marburg , Germany.
Julia
J
Schlereth
a Institut für Pharmazeutische Chemie, Philipps-Universität Marburg , Marburg , Germany.
Arnold
A
Grünweller
b Institut für Virologie, Philipps-Universität Marburg , Marburg , Germany.
Nadine
N
Biedenkopf
b Institut für Virologie, Philipps-Universität Marburg , Marburg , Germany.
Stephan
S
Becker
a Institut für Pharmazeutische Chemie, Philipps-Universität Marburg , Marburg , Germany.
Roland K
RK
Hartmann
D001482:Base Composition; D001483:Base Sequence; D029043:Ebolavirus / Q000235:genetics* / Q000378:metabolism*; D024202:Electrophoretic Mobility Shift Assay; D016679:Genome, Viral; D019142:Hemorrhagic Fever, Ebola / Q000821:virology; D009690:Nucleic Acid Conformation; D011401:Promoter Regions, Genetic; D016372:RNA, Antisense / Q000737:chemistry / Q000235:genetics; D012333:RNA, Messenger / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D012367:RNA, Viral / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*; D016601:RNA-Binding Proteins / Q000737:chemistry / Q000378:metabolism*; D017384:Sequence Deletion; D013379:Substrate Specificity; D014157:Transcription Factors / Q000737:chemistry / Q000378:metabolism*; D014158:Transcription, Genetic; D014764:Viral Proteins / Q000737:chemistry / Q000378:metabolism*; D014779:Virus Replication
D016372:RNA, Antisense; D012333:RNA, Messenger; D012367:RNA, Viral; D016601:RNA-Binding Proteins; D014157:Transcription Factors; C479897:VP30 protein, ebola virus; D014764:Viral Proteins
Ebola virus (EBOV); RNA binding specificity; VP30; electrophoretic/gel mobility shift assay; transcription factor